Research

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 

UVA Professor Shawn Russell helps those with disabilities take on skiing, proving that biomechanics research has real-life applications that can change lives for the better in Virginia and beyond.

NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

An app designed by researchers at the University of Virginia is proving that 'warm technology' - personalized and personal - can have an impact on patient engagement and care management.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

UVA's Center for Applied Biomechanics is taking a leadership role in analyzing populations with heightened vulnerability to traffic-related injury or death, specifically women and obese passengers.

A new UVA Cancer Center Without Walls initiative will empower Southwest Virginia residents to lead projects to better detect and prevent cancer in the region.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

The University has approved an academic affiliation with INOVA Health System and George Mason University.